TABLE 6.
Summary of the M27 method developed by the NCCLSa
| Factor | Implementation in the M27 methodology |
|---|---|
| Methodology | Broth macrodilution, 1-ml final volume; or broth microdilution, 0.2-ml final volume |
| Medium | RPMI 1640 containing 0.165 M MOPSb (pH 7.0) |
| Fungal inoculum | (0.5–2.5) × 103 organisms |
| Incubation temp | 35°C |
| Incubation time | 48 h (Candida species) or 72 h (Cryptococcus neoformans) |
| End point | Amphotericin B, optically clear tube; azoles and 5-FC, 80% reduction in turbidity by comparison with growth control |
| Drug and quality control (QC) isolates | Two QC isolates and corresponding QC ranges established via the M23 procedure are specified for amphotericin B, flucytosine, ketoconazole, itraconazole, and fluconazole |
Adapted from reference 217 with permission of the publisher.
Morpholinepropanesulfonic acid.